{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:59:52Z","timestamp":1777121992639,"version":"3.51.4"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We conducted a descriptive study of the physicians\u2019 evidence\u2013practice gap for adults covered by the 2017 clinical practice guidelines for the management of antineutrophil cytoplasmic antibody-associated vasculitis in Japan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This web-based survey, conducted between January and February 2021, involved physicians who had treated at least five patients in the preceding year at a regional core hospital. The outcome was the physicians\u2019 experience in treating patients with microscopic polyangiitis or granulomatosis with polyangiitis [prevalence with 95% confidence intervals (CIs)], defined as treating at least 60% of their patients with the recommended therapy during the year. A modified Poisson regression analysis was performed to explore the factors associated with concordance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 202 participants included 49 pulmonologists, 65 nephrologists, 61 rheumatologists, and other physicians. The concordance was 31.5% (95% CI, 25.1\u201338.5) of physicians who used cyclophosphamide or rituximab for the induction of remission. Rheumatology showed the highest concordance with published evidence (risk ratio\u2009=\u20092.4; 95% CI, 1.10\u20135.22, p\u2009=\u2009.03).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results suggest an evidence\u2013practice gap, which varies substantially among subspecialties. Further studies and a new promotional initiative are necessary to close this gap in clinical practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roac118","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T12:22:05Z","timestamp":1664626925000},"page":"990-997","source":"Crossref","is-referenced-by-count":10,"title":["Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: A cross-sectional web-questionnaire survey"],"prefix":"10.1093","volume":"33","author":[{"given":"Yoshia","family":"Miyawaki","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama, Japan"},{"name":"Center for Innovative Clinical Medicine, Okayama University Hospital , Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University , Wakayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Anan","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Saiseikai Kumamoto Hospital , Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Japan Community Healthcare, Organization Chukyo Hospital , Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine College Hospital Hemocatharsis treatment part, University of Miyazaki Hospital , Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-0818","authenticated-orcid":false,"given":"Ken-Ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama, Japan"},{"name":"Department of Clinical Epidemiology, Kochi Medical School, Kochi University , Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nagasaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ome Municipal General Hospital, Ome , Tokyo, Japan"},{"name":"Department of Rheumatology, Tokyo Medical and Dental University (TMDU) , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Bando","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary Medicine, Jichi Medical University , Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama, Japan"},{"name":"Department of Medicine, Kawasaki Medical School General Medical Center and Department of Medical Care Work, Kawasaki College of Allied Health Professions , Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kaname","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Kyorin University School of Medicine , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-2603","authenticated-orcid":false,"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Division of Epidemiology and Pharmacoepidemiology, School of Medicine, Tokyo Women\u2019s Medical University of Medicine , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-2954","authenticated-orcid":false,"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine , Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"2023082610105702800_R1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023082610105702800_R2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2023082610105702800_R3","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8392542","article-title":"A review of primary vasculitis mimickers based on the Chapel Hill Consensus Classification","volume":"2020","author":"Zarka","year":"2020","journal-title":"Int J Rheumatol"},{"key":"2023082610105702800_R4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener\u2019s granulomatosis)","volume":"2","author":"Walton","year":"1958","journal-title":"Br Med J"},{"key":"2023082610105702800_R5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023082610105702800_R6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14397595.2018.1500437","article-title":"2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis","volume":"29","author":"Harigai","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2023082610105702800_R7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/14397595.2018.1500111","article-title":"Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis","volume":"29","author":"Nagasaka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2023082610105702800_R8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3899\/jrheum.130602","article-title":"Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan","volume":"41","author":"Furuta","year":"2014","journal-title":"J Rheumatol"},{"key":"2023082610105702800_R9","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0815-y","article-title":"Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study","volume":"17","author":"Sada","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2023082610105702800_R10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.170548","article-title":"Routine use of quantitative disease activity measurements among US rheumatologists: implications for treat-to-target management strategies in rheumatoid arthritis","volume":"45","author":"Curtis","year":"2018","journal-title":"J Rheumatol"},{"key":"2023082610105702800_R11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/acr.22681","article-title":"Evaluating adherence to a treat-to-target protocol in recent-onset rheumatoid arthritis: reasons for compliance and hesitation","volume":"68","author":"Markusse","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2023082610105702800_R12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdent.2020.103469","article-title":"Evidence-practice gap in minimal intervention dentistry: findings from a dental practice-based research network","volume":"102","author":"Kakudate","year":"2020","journal-title":"J Dent"},{"key":"2023082610105702800_R13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acr.23294","article-title":"Cluster-randomized trial of a behavioral intervention to incorporate a treat-to-target approach to care of US patients with rheumatoid arthritis","volume":"70","author":"Harrold","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2023082610105702800_R14","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology"},{"key":"2023082610105702800_R15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjd.13377","article-title":"Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8","volume":"172","author":"Furue","year":"2015","journal-title":"Br J Dermatol"},{"key":"2023082610105702800_R16","doi-asserted-by":"crossref","first-page":"i83","DOI":"10.1093\/ndt\/gfu385","article-title":"Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan","volume":"30","author":"Hirayama","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2023082610105702800_R17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10157-012-0740-1","article-title":"Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey","volume":"17","author":"Yamagata","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2023082610105702800_R18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2023082610105702800_R19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2023082610105702800_R20","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/art.39317","article-title":"Incidence of malignancies in patients with antineutrophil cytoplasmic antibody-associated vasculitis diagnosed between 1991 and 2013","volume":"67","author":"Rahmattulla","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023082610105702800_R21","article-title":"Cyclophosphamide: as bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases","volume":"144","author":"Dan","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"2023082610105702800_R22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2023082610105702800_R23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/mr\/roab088","article-title":"Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database","volume":"32","author":"Nagasaka","year":"2021","journal-title":"Modern Rheumatology"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roac118\/46439565\/roac118.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/33\/5\/990\/51269899\/roac118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/33\/5\/990\/51269899\/roac118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T10:12:28Z","timestamp":1693044748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/33\/5\/990\/6743165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,1]]},"published-print":{"date-parts":[[2023,8,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roac118","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2022,10,1]]}}}